CY1109553T1 - Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv - Google Patents
Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hivInfo
- Publication number
- CY1109553T1 CY1109553T1 CY20091101257T CY091101257T CY1109553T1 CY 1109553 T1 CY1109553 T1 CY 1109553T1 CY 20091101257 T CY20091101257 T CY 20091101257T CY 091101257 T CY091101257 T CY 091101257T CY 1109553 T1 CY1109553 T1 CY 1109553T1
- Authority
- CY
- Cyprus
- Prior art keywords
- aryl
- group
- different
- alkyl
- substituents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Τα παράγωγα της κινολεΐνης ανταποκρίνονται στον τύπο (I) στον οποίο: τα Ra, Rb και Rc, όμοια ή διαφορετικά μεταξύ τους, παριστούν έναν ή περισσότερους υποκατάστατες, οι οποίοι κατέχουν μία οποιαδήποτε θέση επί των δακτυλίων, όπου αυτός ή αυτοί οι υποκαταστάτες επιλέγονται μεταξύ μίας ομάδας -(CH2)n-Y ή -CH=CH-Y, όπου το Υ είναι αλογόνο, -OH, -OR, -COH, -COR, COOH, -COOR, -COH, -COR, -CONH2, -CON(Rx, Ry), -CH=NOH, -CO-CH=NOH, -NH2, -N(Rx, Ry), -NΟ2, -PO(OR)2, -SH2,-SR, -SΟ2R, -SO2NHR, -CN ή Z(RC), όπου το R είναι αλκύλιο με 1 έως 8 άτομα άνθρακα, ή αρύλιο ή ετεροκυκλική ομάδα, τα Rx και Ry, όμοια ή διαφορετικά, είναι αλκύλιο με 1 έως 5 άτομα άνθρακα, το Ζ είναι αρύλιο ή ετεροκυκλική ομάδα και το n είναι μηδέν ή ένας ακέραιος με 1 έως 5, ενώ το Rb μπορεί να παριστά εξ άλλου υδρογόνο και όταν το Υ είναι -COOH ή -COOR στο Rc, το Ζ, αν παριστά αρύλιο, περιλαμβάνει τουλάχιστον 3 υποκαταστάτες ή ο πυρήνας κινολεΐνης είναι τρις-υποκατασταθείς, το Χ είναι ένας διπλός αιθυλενικός δεσμός, μία ομάδα -(CH2)n- όπου το n είναι ένας ακέραιος από 1 έως 5 ή μία ομάδα -CH(Rd)-CH(Re)-, όπου τα Rd και Re, όμοια ή διαφορετικά, παριστούν υδρογόνο, αλογόνο, υδροξύλιο ή εποξικό· ή μία ομάδα -(CH2)n’, O-C(O)-O-(CH2)m-, -(CH2)n, C(O)-O-(CH2)m, -(CH2)n, -O-(CH2)m, -(CH2)n, -N(Q)-(CH2)m- ή -(CH2)n, -S(O)t-(CH2)m-, όπου n = 1 έως 8, m = 0 έως 8, t = 0, 1 ή 2 και Q = Η, αρύλιο ή αλκύλιο, καθώς και τα φαρμακευτικά αποδεκτά άλατα αυτών των παραγώγων, οι διαστερεομερείς μορφές τους και οι εναντιομερείς μορφές τους. Εφαρμογή υπό τύπο φαρμάκων με δράση αναστολής της ιντεγράσης του HIV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704289A FR2761687B1 (fr) | 1997-04-08 | 1997-04-08 | Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques |
EP98920581A EP0975597B1 (fr) | 1997-04-08 | 1998-04-07 | Derives de quinoleines en tant qu'inhibiteurs de la vih integrase |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1109553T1 true CY1109553T1 (el) | 2014-08-13 |
Family
ID=9505648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091101257T CY1109553T1 (el) | 1997-04-08 | 2009-12-01 | Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv |
Country Status (12)
Country | Link |
---|---|
US (1) | US6670377B1 (el) |
EP (1) | EP0975597B1 (el) |
JP (1) | JP4697679B2 (el) |
AT (1) | ATE441634T1 (el) |
CA (1) | CA2286385C (el) |
CY (1) | CY1109553T1 (el) |
DE (1) | DE69841119D1 (el) |
DK (1) | DK0975597T3 (el) |
ES (1) | ES2332434T3 (el) |
FR (1) | FR2761687B1 (el) |
PT (1) | PT975597E (el) |
WO (1) | WO1998045269A1 (el) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2321348A1 (en) | 2000-09-27 | 2002-03-27 | Blaise Magloire N'zemba | Aromatic derivatives with hiv integrase inhibitory properties |
FR2819507B1 (fr) * | 2001-01-17 | 2007-09-28 | Inst Rech Developpement Ird | Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus |
EP2033952B1 (en) | 2001-03-01 | 2012-08-29 | Shionogi&Co., Ltd. | Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
FR2830863B1 (fr) | 2001-10-12 | 2004-01-30 | Bioalliance Pharma | Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives |
FR2839646B1 (fr) | 2002-05-17 | 2008-04-11 | Bioalliance Pharma | Utilisation de derives de quinoleine a effet anti-integrase et ses applications |
ATE404537T1 (de) | 2002-08-13 | 2008-08-15 | Shionogi & Co | Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung |
BRPI0306214B1 (pt) * | 2002-11-20 | 2017-08-08 | Japan Tobacco Inc. | 4-oxoquinoline compound and use of this as a hiv integrase inhibitor |
KR100866296B1 (ko) * | 2004-05-20 | 2008-11-11 | 니뽄 다바코 산교 가부시키가이샤 | 4―옥소퀴놀린 화합물의 안정한 결정체 |
WO2005113509A1 (en) | 2004-05-20 | 2005-12-01 | Japan Tobacco Inc. | Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
JP2008542352A (ja) * | 2005-06-01 | 2008-11-27 | ビオアリアンス ファルマ | キノリン化合物及び他のhiv感染治療薬を含む相乗作用のコンビネーション |
IN2014CN00613A (el) | 2006-03-06 | 2015-08-21 | Japan Tobacco Inc | |
WO2008154484A1 (en) * | 2007-06-08 | 2008-12-18 | Mannkind Corporation | Ire-1a inhibitors |
RU2503679C2 (ru) * | 2007-11-15 | 2014-01-10 | Джилид Сайенсиз, Инк. | Ингибиторы репликации вируса иммунодефицита человека |
SI2220076T1 (sl) * | 2007-11-15 | 2012-05-31 | Gilead Sciences Inc | Inhibitorji replikacije virusa humane imunske pomankljivosti |
WO2009062308A1 (en) * | 2007-11-16 | 2009-05-22 | Boehringer Ingelheim International Gmbh | Inhibitors of human immunodeficiency virus replication |
EA201200631A1 (ru) * | 2007-11-16 | 2012-11-30 | Джилид Сайенсиз, Инк. | Ингибиторы репликации вируса иммунодефицита человека |
EP2147912A1 (en) | 2008-07-23 | 2010-01-27 | BioAlliance Pharma | Styrylquinolines, their process of preparation and their therapeutic uses |
EP2149557A1 (en) * | 2008-07-23 | 2010-02-03 | BioAlliance Pharma | Styrylquinolines, their process of preparation and their therapeutic uses |
EP2147913A1 (en) | 2008-07-23 | 2010-01-27 | BioAlliance Pharma | Styrylquinolines, their process of preparation and their therapeutic uses |
PE20130525A1 (es) * | 2010-07-02 | 2013-05-05 | Gilead Sciences Inc | Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih |
CA2860015C (en) * | 2011-12-22 | 2020-07-07 | Universite Laval | Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1) |
US20160083343A1 (en) | 2013-03-15 | 2016-03-24 | Global Blood Therapeutics, Inc | Compounds and uses thereof for the modulation of hemoglobin |
EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
MX2021003158A (es) | 2018-09-18 | 2021-07-16 | Nikang Therapeutics Inc | Derivados de anillo tricíclico condensado como inhibidores de la fosfatasa de homología a src 2. |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59152891A (ja) * | 1983-02-18 | 1984-08-31 | Yamada Kagaku Kogyo Kk | 発色性記録材料 |
DK282986A (da) * | 1985-06-18 | 1987-02-24 | Merck Frosst Canada Inc | Substitueret quinolin og farmaceutisk praeparat indeholdende en saadan forbindelse |
EP0219307A3 (en) * | 1985-10-16 | 1987-10-14 | Merck Frosst Canada Inc. | 2-substituted quinolines |
JPS61189988A (ja) * | 1986-08-11 | 1986-08-23 | Yamada Kagaku Kogyo Kk | 発色性記録材料 |
JPH01199979A (ja) * | 1987-04-07 | 1989-08-11 | Kanebo Ltd | 新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤 |
EP0318093A3 (en) | 1987-11-25 | 1990-12-05 | Merck Frosst Canada Inc. | Diarylquinoline diacids and their use as medicaments |
US5438141A (en) * | 1993-05-21 | 1995-08-01 | Merck Frosst Canada, Inc. | Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
EP0643045B1 (de) * | 1993-09-10 | 2000-03-08 | Novartis AG | Chinolin-Verbindungen als Leukotriene Antagonisten |
GB9414590D0 (en) * | 1994-07-20 | 1994-09-07 | Leo Pharm Prod Ltd | Chemical compounds |
ES2103180B1 (es) * | 1994-08-01 | 1998-04-01 | Menarini Lab | Fenilacetamidas con accion antagonista de los leucotrienos. |
EP0725063A1 (de) * | 1995-02-01 | 1996-08-07 | Ciba-Geigy Ag | Chinolin-Derivate |
AU4172197A (en) * | 1996-09-10 | 1998-04-02 | Pharmacia & Upjohn Company | 8-hydroxy-7-substituted quinolines as anti-viral agents |
-
1997
- 1997-04-08 FR FR9704289A patent/FR2761687B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-07 AT AT98920581T patent/ATE441634T1/de active
- 1998-04-07 JP JP54245998A patent/JP4697679B2/ja not_active Expired - Fee Related
- 1998-04-07 DK DK98920581T patent/DK0975597T3/da active
- 1998-04-07 DE DE69841119T patent/DE69841119D1/de not_active Expired - Lifetime
- 1998-04-07 EP EP98920581A patent/EP0975597B1/fr not_active Expired - Lifetime
- 1998-04-07 WO PCT/FR1998/000701 patent/WO1998045269A1/fr active Application Filing
- 1998-04-07 PT PT98920581T patent/PT975597E/pt unknown
- 1998-04-07 US US09/402,858 patent/US6670377B1/en not_active Expired - Fee Related
- 1998-04-07 ES ES98920581T patent/ES2332434T3/es not_active Expired - Lifetime
- 1998-04-07 CA CA2286385A patent/CA2286385C/fr not_active Expired - Fee Related
-
2009
- 2009-12-01 CY CY20091101257T patent/CY1109553T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2286385A1 (fr) | 1998-10-15 |
ES2332434T3 (es) | 2010-02-04 |
FR2761687B1 (fr) | 2000-09-15 |
PT975597E (pt) | 2010-01-04 |
FR2761687A1 (fr) | 1998-10-09 |
JP2001518890A (ja) | 2001-10-16 |
EP0975597B1 (fr) | 2009-09-02 |
US6670377B1 (en) | 2003-12-30 |
JP4697679B2 (ja) | 2011-06-08 |
EP0975597A1 (fr) | 2000-02-02 |
DK0975597T3 (da) | 2009-11-02 |
CA2286385C (fr) | 2011-02-01 |
DE69841119D1 (de) | 2009-10-15 |
WO1998045269A1 (fr) | 1998-10-15 |
ATE441634T1 (de) | 2009-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109553T1 (el) | Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv | |
WO2000010965A3 (en) | Quaternary ammonium salts and their use as anti-hiv agents | |
PT87700A (pt) | Process for the preparation of a new pyrazolopyridine compound | |
MX9504349A (es) | Derivados de aroilpiperidina. | |
CA2134359A1 (en) | New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) | |
EA200100970A1 (ru) | Аминопроизводные как ингибиторы протеазы | |
DK0620215T3 (da) | 1H-indol-3-acetamidderivater som sPLA2-inhibitorer | |
TR200100432T2 (tr) | Hepatit C inhibitörü tri-peptidler | |
IE831564L (en) | N-substituted imidazoles | |
NO20023995D0 (no) | 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse | |
WO2003068750A1 (fr) | Inhibiteur de jnk | |
EA200600348A1 (ru) | Новые соединения | |
HUP9800295A2 (hu) | Szubsztituált heterociklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények, intermedierjeik | |
HRP20010573B1 (en) | Tricyclic inhibitors of poly(adp-ribose) polymerases | |
DK0848004T3 (da) | Pyrrolidinderivater med inhiberende aktivitet mod phospholipase A2 | |
RS51047B (sr) | Derivati 4-tetrazolil-4-fenilpiperidina za lečenje bola | |
IL148932A0 (en) | INHIBITORS OF αLβ2 MEDIATED CELL ADHESION | |
DK0916646T3 (da) | Fremgangsmåde til fremstillingen af en substitueret 2,5-diamino-3-hydroxyhexan | |
HUP0101688A2 (hu) | Heterociklussal szubsztituált amidok és alkalmazásuk gyógyszerkészítmények előállítására | |
DE69824450D1 (de) | Biphenylamidin-derivate | |
DK0902018T3 (da) | 2-(arylpheny)amino-imidazolinderivater | |
EA200401482A1 (ru) | Ненуклезидные ингибиторы обратной транскриптазы | |
DK0785789T3 (da) | Diazepinindoler som phosphodiesterase IV-inhibitorer | |
DK0701551T3 (da) | 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister | |
YU200791A (sh) | Trifluorometil 1-karba (1-detia) cefemi |